240 related articles for article (PubMed ID: 17569811)
1. Secondary prevention for patients following a myocardial infarction: summary of NICE guidance.
Skinner JS; Cooper A; Feder GS;
Heart; 2007 Jul; 93(7):862-4. PubMed ID: 17569811
[TBL] [Abstract][Full Text] [Related]
2. Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction.
Skinner JS; Minhas R
Heart; 2007 Jul; 93(7):864-6. PubMed ID: 17569812
[No Abstract] [Full Text] [Related]
3. An intervention to improve secondary prevention of coronary heart disease.
Bailey TC; Noirot LA; Blickensderfer A; Rachmiel E; Schaiff R; Kessels A; Braverman A; Goldberg A; Waterman B; Dunagan WC
Arch Intern Med; 2007 Mar; 167(6):586-90. PubMed ID: 17389290
[TBL] [Abstract][Full Text] [Related]
4. [Secondary prevention after myocardial infarction].
Czuriga I
Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
[TBL] [Abstract][Full Text] [Related]
5. Interventions to improve guideline compliance following coronary artery bypass grafting.
Yam FK; Akers WS; Ferraris VA; Smith K; Ramaiah C; Camp P; Flynn JD
Surgery; 2006 Oct; 140(4):541-7; discussion 547-52. PubMed ID: 17011901
[TBL] [Abstract][Full Text] [Related]
6. Comparison of secondary prevention of heart disease in Europe: lifestyle getting worse, therapy getting better in Ireland.
Hall M; McGettigan M; O'Callaghan P; Graham I; Shelley E; Feely J
Ir Med J; 2002 Oct; 95(9):272-4. PubMed ID: 12469998
[TBL] [Abstract][Full Text] [Related]
7. Use of evidence-based management for acute coronary syndrome.
Tang E; Wong CK; Wilkins G; Herbison P; Williams M; Kay P; Restieaux N
N Z Med J; 2005 Oct; 118(1223):U1678. PubMed ID: 16224502
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention of myocardial infarction: putting the evidence to use.
Herzog E; Javed F
Arch Intern Med; 2010 Aug; 170(15):1381-2. PubMed ID: 20696965
[No Abstract] [Full Text] [Related]
9. A "poly-portfolio" for secondary prevention: a strategy to reduce subsequent events by up to 97% over five years.
Robinson JG; Maheshwari N
Am J Cardiol; 2005 Feb; 95(3):373-8. PubMed ID: 15670547
[TBL] [Abstract][Full Text] [Related]
10. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M; Malmberg K; Ohrvik J; Rydén L;
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
[TBL] [Abstract][Full Text] [Related]
11. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological prevention of coronary relapses in Italian clinical practice: a literature review].
Pedrinelli R; Ciccone M; Novo S; Catapano AL
G Ital Cardiol (Rome); 2012 Nov; 13(11):734-40. PubMed ID: 23096582
[TBL] [Abstract][Full Text] [Related]
13. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
Fox DJ; Kibiro M; Eichhöfer J; Curzen NP
Postgrad Med J; 2005 Jun; 81(956):401-3. PubMed ID: 15937208
[TBL] [Abstract][Full Text] [Related]
14. Reduction in sex-based mortality difference with implementation of new cardiology guidelines.
Novack V; Cutlip DE; Jotkowitz A; Lieberman N; Porath A
Am J Med; 2008 Jul; 121(7):597-603.e1. PubMed ID: 18538296
[TBL] [Abstract][Full Text] [Related]
15. What do we really know about secondary prevention after myocardial infarction?
Wielgosz AT
Can J Cardiol; 1995 Jan; 11 Suppl A():31A-32A. PubMed ID: 7850674
[TBL] [Abstract][Full Text] [Related]
16. Drug secondary prevention in postmenopausal women with ischemic heart disease.
Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
[TBL] [Abstract][Full Text] [Related]
17. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
[TBL] [Abstract][Full Text] [Related]
18. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.
Choudhry NK; Avorn J; Antman EM; Schneeweiss S; Shrank WH
Health Aff (Millwood); 2007; 26(1):186-94. PubMed ID: 17211028
[TBL] [Abstract][Full Text] [Related]
19. Secondary prevention after acute myocardial infarction and coronary revascularisation: focus on Angiotensin converting enzyme inhibitors.
Kaski JC; Fernandez-Berges D
Cardiovasc Drugs Ther; 2008 Jun; 22(3):185-91. PubMed ID: 18317916
[TBL] [Abstract][Full Text] [Related]
20. Secondary prevention of coronary artery disease.
Hall SL; Lorenc T
Am Fam Physician; 2010 Feb; 81(3):289-96. PubMed ID: 20112887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
